Clinical trials
Completed Phase 2 Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
373 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 8 |
| 2004 | 18 |
| 2005 | 17 |
| 2006 | 17 |
| 2007 | 17 |
| 2008 | 29 |
| 2009 | 13 |
| 2010 | 12 |
| 2011 | 12 |
| 2012 | 12 |
| 2013 | 14 |
| 2014 | 10 |
| 2015 | 16 |
| 2016 | 10 |
| 2017 | 21 |
| 2018 | 10 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 20 |
| 2022 | 7 |
| 2023 | 21 |
| 2024 | 30 |
| 2025 | 25 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 373 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 16 |
| AstraZeneca | 13 |
| Eli Lilly and Company | 10 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 7 |
| Novartis Pharmaceuticals | 7 |
| Novo Nordisk A/S | 7 |
| Mayo Clinic | 6 |
| Merck Sharp & Dohme LLC | 6 |
| Orexigen Therapeutics, Inc | 6 |
| Pfizer | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 373 |
| Overweight | 123 |
| Weight Loss | 51 |
| Diabetes Mellitus, Type 2 | 40 |
| Diabetes Mellitus | 28 |
| Insulin Resistance | 28 |
| Metabolic Syndrome | 20 |
| Hypertension | 14 |
| Non-alcoholic Fatty Liver Disease | 12 |
| Body Weight | 10 |
Trials
Showing 1 to 25 of 373. Each trial links to its page on Pharma Observatory.
273 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.